Remote Monitored Systems PLC (LON:RMS) said its subsidiary Pharm 2 Farm Limited’s (P2F) Pro Larva face mask has been approved as a Class 1 medical device by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
The company said the approval followed the self-certification of the mask to EN 14683 standards in accordance with government guidelines earlier this year, allowing the use of the associated CE Mark.
READ: Remote Monitored Systems subsidiary making headway
RMS added that with MHRA approval now secure it will continue to comply with necessary regulations.
Shares were 5.2% lower at 1.9p in early deals on Thursday.